| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.71B | 10.58B | 10.24B | 9.28B | 8.31B | 7.52B |
| Gross Profit | 5.29B | 5.22B | 5.05B | 4.68B | 4.58B | 4.57B |
| EBITDA | 3.15B | 3.06B | 2.77B | 2.38B | 2.05B | 1.97B |
| Net Income | 1.20B | 1.18B | 1.17B | 962.76M | 943.56M | 1.24B |
Balance Sheet | ||||||
| Total Assets | 10.47B | 11.15B | 9.62B | 8.29B | 7.46B | 6.31B |
| Cash, Cash Equivalents and Short-Term Investments | 3.02B | 1.73B | 1.90B | 1.44B | 979.40M | 1.45B |
| Total Debt | 0.00 | 0.00 | 314.55M | 314.55M | 514.55M | 17.15M |
| Total Liabilities | 1.86B | 2.64B | 2.28B | 2.10B | 2.21B | 1.95B |
| Stockholders Equity | 8.52B | 8.43B | 7.25B | 6.10B | 5.16B | 4.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.04B | 1.85B | 1.99B | 641.94M | 1.26B |
| Operating Cash Flow | 0.00 | 2.11B | 1.97B | 2.31B | 698.24M | 1.32B |
| Investing Cash Flow | 0.00 | -1.97B | -1.50B | -1.65B | -1.67B | -1.15B |
| Financing Cash Flow | 0.00 | -312.95M | 825.00K | -199.91M | 493.74M | 620.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥17.48B | 17.99 | ― | 0.17% | 31.39% | 13.12% | |
73 Outperform | ¥33.32B | 16.59 | 19.71% | 3.09% | 3.44% | 79.35% | |
68 Neutral | ¥20.73B | 9.96 | ― | ― | 17.93% | 91.21% | |
68 Neutral | ¥23.00B | 119.61 | ― | ― | 6.33% | 14.82% | |
68 Neutral | ¥31.01B | 27.58 | ― | 0.39% | 30.59% | 65.14% | |
62 Neutral | ¥43.48B | 50.91 | ― | ― | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |